Treatment for COVID-19: An overview

C Stasi, S Fallani, F Voller, C Silvestri - European journal of pharmacology, 2020 - Elsevier
… The RECOVERY Trial aims to identify effective drugs in the treatment of adults
hospitalised with COVID-19, particularly focusing on: low dosage dexamethasone; lopinavir-ritonavir; …

The development of COVID-19 treatment

Y Yuan, B Jiao, L Qu, D Yang, R Liu - Frontiers in immunology, 2023 - frontiersin.org
treatment with molnupiravir in nonhospitalized, unvaccinated adults with mild-to-moderate
COVID-19… of unvaccinated adults with COVID-19 could be reduced by early treatment with …

Remdesivir for the treatment of Covid-19

JH Beigel, KM Tomashek, LE Dodd… - … England Journal of …, 2020 - Mass Medical Soc
… agents among hospitalized adults with laboratory-confirmed Covid-19, we designed an …
of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with …

Remdesivir for the treatment of Covid-19—preliminary report

JH Beigel, KM Tomashek, LE Dodd… - … England Journal of …, 2020 - discovery.ucl.ac.uk
… agents among hospitalized adults with laboratory-confirmed Covid-19, we designed an …
of the Adaptive Covid-19 Treatment Trial (ACTT-1), in which we evaluated treatment with …

COVID19 and older adults: what we know

Z Shahid, R Kalayanamitra… - Journal of the …, 2020 - Wiley Online Library
treatment for COVID-19, and the State Council of China has stated that chloroquine has
demonstrated marked efficacy in treating COVID-19–… with confirmed COVID-19 infection showed …

Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19

J Hammond, H Leister-Tebbe, A Gardner… - … England Journal of …, 2022 - Mass Medical Soc
Covid-19 and five times as likely to die from Covid-19 as patients without those conditions.
Mortality among older adults … A need exists for safe and effective oral Covid-19 treatments that …

Emerging treatment strategies for COVID-19 infection

M Gavriatopoulou, I Ntanasis-Stathopoulos… - Clinical and …, 2021 - Springer
… Recently the results of a double-blind, randomized, placebo-controlled trial of intravenous
remdesivir in adults hospitalized with Covid-19 disease and evidence of lower respiratory tract …

Baricitinib plus remdesivir for hospitalized adults with Covid-19

AC Kalil, TF Patterson, AK Mehta… - … England Journal of …, 2021 - Mass Medical Soc
Covid-19 treatments, patients could receive those treatments. In the absence of a written policy,
other experimental treatment … intended as specific treatment for Covid-19 were prohibited…

Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan

X Li, S Xu, M Yu, K Wang, Y Tao, Y Zhou, J Shi… - Journal of Allergy and …, 2020 - Elsevier
… medical care for adult patients with COVID-19 in Wuhan. All cases with COVID-19 enrolled in
… 4 and the diagnostic and treatment guideline for COVID-19 issued by the Chinese National …

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo …

VC Marconi, AV Ramanan, S de Bono… - The lancet Respiratory …, 2021 - thelancet.com
… in combination with standard of care for the treatment of hospitalised adults with COVID-19. …
therapies for the treatment of COVID-19. Management of COVID-19 was supportive, and few …